EUVIMEDEUVIMED entdecken
Open Access

T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia

Philipp M Roessner iD, Isabelle Seufert iD, Vicente Chapaprieta iD, Ruparoshni Jayabalan, Hannah Briesch iD, Ramon Massoni-Badosa iD, Pavle Boskovic iD, Julian Benckendorff, Tobias Roider iD, Lavinia Arseni, Mariana Coelho iD, Supriya Chakraborty iD und 31 weitere

Blood · 01.08.2024 · 144 (5) · 510-524

DOI: 10.1182/blood.2023021990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, erschienen am 01.08.2024. Verfasst von Philipp M Roessner und 42 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, T-Box Domain Proteins, Cell Proliferation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The T-box transcription factor T-bet is known as a master regulator of the T-cell response but its role in malignant B cells has not been sufficiently explored. Here, we conducted single-cell resolved multi-omics analyses of malignant B cells from patients with chronic lymphocytic leukemia (CLL) and studied a CLL mouse model with a genetic knockout of Tbx21. We found that T-bet acts as a tumor suppressor in malignant B cells by decreasing their proliferation rate. NF-κB activity, induced by inflammatory signals provided by the microenvironment, triggered T-bet expression, which affected promoter-proximal and distal chromatin coaccessibility and controlled a specific gene signature by mainly suppressing transcription. Gene set enrichment analysis identified a positive regulation of interferon signaling and negative control of proliferation by T-bet. In line, we showed that T-bet represses cell cycling and is associated with longer overall survival of patients with CLL. Our study uncovered a novel tumor suppressive role of T-bet in malignant B cells via its regulation of inflammatory processes and cell cycling, which has implications for the stratification and therapy of patients with CLL. Linking T-bet activity to inflammation explains the good prognostic role of genetic alterations in the inflammatory signaling pathways in CLL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellT-Box Domain ProteinsCell ProliferationAnimalsHumansMiceB-LymphocytesMice, KnockoutGene Expression Regulation, LeukemicNF-kappa BT-bet Transcription Factor

Substanzen

T-Box Domain ProteinsT-bet Transcription FactorNF-kappa B

Autor:innen und Institutionen

  • Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.
  • Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany.
  • Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Single Cell Genomics, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Department of Pathology, University Hospital Ulm, Ulm, Germany.

ORCID-Profile: Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta, Hannah Briesch, Ramon Massoni-Badosa, Pavle Boskovic, Tobias Roider, Mariana Coelho, Supriya Chakraborty, Markus Muckenhuber, Sonia Rodriguez-Rodriguez, Alice Bonato, Sophie A Herbst, Marc Zapatka, Clare Sun, Helene Kretzmer, Thomas Naake, Peter-Martin Bruch, Felix Czernilofsky, Elisa Ten Hacken, Martin Schneider, Dominic Helm, Deyan Y Yosifov, Joseph Kauer, Moritz Bewarder, Adrian Wiestner, Jan A Burger, Dimitar G Efremov, Peter Lichter, Sascha Dietrich, José I Martin-Subero, Karsten Rippe, Martina Seiffert

Zitieren

APA

Roessner, P. M., Seufert, I., Chapaprieta, V., Jayabalan, R., Briesch, H., Massoni-Badosa, R., Boskovic, P., Benckendorff, J., Roider, T., Arseni, L., Coelho, M., Chakraborty, S., Vaca, A. M., Sivina, M., Muckenhuber, M., Rodriguez-Rodriguez, S., Bonato, A., Herbst, S. A., Zapatka, M., …, & Seiffert, M. (2024). T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood, 144(5), 510-524. https://doi.org/10.1182/blood.2023021990

Vancouver

Roessner PM, Seufert I, Chapaprieta V, Jayabalan R, Briesch H, Massoni-Badosa R, et al. T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood. 2024;144(5):510-524. doi:10.1182/blood.2023021990

BibTeX
@article{Roessner2024,
  author = {Roessner, Philipp M and Seufert, Isabelle and Chapaprieta, Vicente and Jayabalan, Ruparoshni and Briesch, Hannah and Massoni-Badosa, Ramon and Boskovic, Pavle and Benckendorff, Julian and Roider, Tobias and Arseni, Lavinia and Coelho, Mariana and Chakraborty, Supriya and Vaca, Alicia M and Sivina, Mariela and Muckenhuber, Markus and Rodriguez-Rodriguez, Sonia and Bonato, Alice and Herbst, Sophie A and Zapatka, Marc and Sun, Clare and Kretzmer, Helene and Naake, Thomas and Bruch, Peter-Martin and Czernilofsky, Felix and Ten Hacken, Elisa and Schneider, Martin and Helm, Dominic and Yosifov, Deyan Y and Kauer, Joseph and Danilov, Alexey V and Bewarder, Moritz and Heyne, Kristina and Schneider, Christof and Stilgenbauer, Stephan and Wiestner, Adrian and Mallm, Jan-Philipp and Burger, Jan A and Efremov, Dimitar G and Lichter, Peter and Dietrich, Sascha and Martin-Subero, José I and Rippe, Karsten and Seiffert, Martina},
  title = {T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia},
  journal = {Blood},
  year = {2024},
  volume = {144},
  number = {5},
  pages = {510--524},
  doi = {10.1182/blood.2023021990}
}
Kostenlos starten →